Fig. 5
From: Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes
The effect of estrogen deficiency and sclerostin inhibition on osteocytes expression of osteoclastogenic regulatory genes. qRT-PCR analysis of gene expression (relative to estrogen treated group) in OCY454 cells 24 h after mechanical stimulation. a CXCL12 expression (N = 3, n = 9), b CXCL14 expression (N = 3, n = 9), c WISP1 expression (N = 3, n = 9) and d DLX5 expression (N = 3, n = 9). E, estrogen treatment; ED, Estrogen deficient; Scl-Ab, Sclerostin antibody. Student’s t-test.* = p < 0.05 and ** = p < 0.01